The novelty of immunotherapies means that physicians and patients lack extensive experience dealing with them.
New diagnostic and therapeutic tools are in development to inform the management of advanced and metastatic disease.
Patients diagnosed with MIBC are at a significant risk for death — which has not greatly improved in the last few decades.
A shift toward multidisciplinary care is inevitable for the treatment of locally advanced and metastatic RCC.
Regular exercise can help patients with cancer deal with issues related to weight gain during treatment.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Hyperthermia Plus Chemotherapy Improves Survival in Soft Tissue Sarcoma
- Survey May Help To Identify Patients With Cancer at Risk of HBV Reactivation
- Fish Consumption and Cancer
- Socioeconomic Status May Preclude Elderly Patients From Receiving Pancreatic Cancer Treatment
- Receptor Agonists With Palonosetron May Reduce Needed Dexamethasone Duration